Saturday, June 28, 2014

Hot Life Sciences Stocks To Invest In Right Now

Hot Life Sciences Stocks To Invest In Right Now: C.R. Bard Inc. (BCR)

C. R. Bard, Inc., together with its subsidiaries, engages in the design, manufacture, packaging, distribution, and sale of medical, surgical, diagnostic, and patient care devices worldwide. It offers vascular, urology, oncology, and surgical specialty products. The company?s vascular products include percutaneous transluminal angioplasty catheters, chronic total occlusions catheters, guidewires, introducers, and accessories; peripheral vascular stents and stent grafts, vena cava filters, and biopsy devices; electrophysiology products, such as electrophysiology laboratory systems and diagnostic, therapeutic, and temporary pacing electrode catheters; and fabrics, meshes, and implantable vascular grafts. Its urology products comprise infection control Foley catheters to reduce the rate of urinary tract infections; surgical slings to treat stress urinary incontinence; fecal incontinence products; natural and synthetic devices to treat pelvic floor and vaginal prolapse; brachyt herapy services, devices, and radioactive seeds to treat prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems; ureteral stents; specialty devices for ureteroscopic procedures and stone removal; and catheter stabilization devices. The company?s oncology products consist of specialty vascular access catheters and ports, vascular access ultrasound devices, dialysis access catheters, and enteral feeding devices to treat and manage various cancers, and other diseases and disorders. Its surgical specialty products include implanted patches and fixation systems for hernia and other soft tissue repairs; irrigation devices for orthopedic, laparoscopic, and gynecological procedures; and products for topical hemostasis. C. R. Bard sells its products directly and through distributors to hospitals, individual health care pr! ofessionals, extended care facilities, and alternate site facilities. The company was founded in 1907 and is based in Murray Hill, New Jersey.

Advisors' Opinion:
  • [By Maria Armental var popups = dojo.query(".socialByline .popC"); popups.forEach]

    A U.S. Food and Drug Administration advisory committee Thursday unanimously recommended the use of C.R. Bard Inc.'s(BCR) Lutonix drug-coated balloon PTA catheter to treat patients with femoral and popliteal arterial blockages.

  • [By Maria Armental and Anna Prior]

    C.R. Bard Inc.(BCR) said its board raised the medical-device maker’s quarterly dividend by 4.8% and authorized the repurchase of up to an additional $500 million of its stock.

  • [By Ben Levisohn]

    Stocks finished mix today, though it’s probably more fair to say they hardly moved at all. Intel (INTC), Facebook (FB) and Achillion Pharmaceuticals (ACHN) gained, while CR Bard (BCR) and eHealth (EHTH) fell.

  • [By Victor Selva]

    CR Bard Inc. (BCR) designs, manufactures, packages, distributes and sells medical, surgical, diagnostic and patient care devices. The company has four main product group categories: vascular, urology, oncology and surgical specialties.

  • source from Top Stocks For 2015:http://www.topstocksblog.com/hot-life-sciences-stocks-to-invest-in-right-now.html

No comments:

Post a Comment